Market Place
Sourcing Support
All News #Library
Biotech
Novartis completes acquisition of Regulus Therapeutics
25 Jun 2025 //
GLOBENEWSWIRE
Regulus Therapeutics Reports Q1 2025 Financial Results
08 May 2025 //
PR NEWSWIRE
Novartis to buy Regulus in up to $1.7 Billion deal
01 May 2025 //
REUTERS
Regulus Therapeutics Completes Phase 1b Trial of RGLS8429 for ADPk
27 Mar 2025 //
PR NEWSWIRE
Regulus Reports Positive Updates On ADPKD Drug Farabursen
29 Jan 2025 //
PR NEWSWIRE
Regulus Announces Participation at Upcoming Investment Conference
26 Nov 2024 //
PR NEWSWIRE
Regulus Reports Q3 2024 Financials & Updates
07 Nov 2024 //
PR NEWSWIRE
Regulus Announces Enrollment Ph1b for Polycystic Kidney Disease
08 Oct 2024 //
PR NEWSWIRE
Regulus Therapeutics Reports Q2 2024 Results And Recent Updates
08 Aug 2024 //
PR NEWSWIRE
Regulus To Join Canaccord Genetic Medicine Webcast
30 Apr 2024 //
PR NEWSWIRE
Regulus Announces First Patient Dosed in Third Cohort of Phase 1b of RGLS8429
02 Nov 2023 //
PR NEWSWIRE
Regulus Announces Positive Data from Phase 1bTrial of RGLS8429
20 Sep 2023 //
PR NEWSWIRE
Regulus Announces Completion of Enrollment in Phase 1b Trial of RGLS8429
13 Sep 2023 //
PR NEWSWIRE
Regulus Announces 1st Patient Dosed 2nd Cohort of Ph1b (MAD) Trial of RGLS8429
27 Jun 2023 //
PR NEWSWIRE
Regulus Announces Update on Preclinical Studies in Amyotrophic Lateral Sclerosis
20 Jun 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.